Experience of Initial Symptoms of Breast Cancer and Triggers for Action in Ethiopia

Author:

Dye Timothy D.12,Bogale Solomon3,Hobden Claire1,Tilahun Yared4,Deressa Teshome5,Reeler Anne1

Affiliation:

1. Division of Global Health Systems and Research, Axios International 75001, Paris, France

2. Department of Public Health, Food Studies and Nutrition, Syracuse University, Syracuse, NY 13210-2938, USA

3. Radiology Department, Addis Ababa University Faculty of Medicine, Tikur Anbessa Hospital, Addis Ababa, Ethiopia

4. Ethiopia Breast Cancer Project, Axios Foundation, Addis Ababa, Ethiopia

5. Ethiopian Cancer Association, Addis Ababa, Ethiopia

Abstract

Objective. This study assessed the initial experiences, symptoms, and actions of patients in Ethiopia ultimately determined to have breast cancer.Methods. 69 participants in a comprehensive breast cancer treatment program at the main national cancer hospital in Ethiopia were interviewed using mixed qualitative and quantitative approaches. Participants’ narratives of their initial cancer experience were coded and analyzed for themes around their symptoms, time to seeking advice, triggers for action, and contextual factors. The assessment was approved by the Addis Ababa University Faculty of Medicine Institutional Review Board.Results. Nearly all women first noticed lumps, though few sought medical advice within the first year (average time to action: 1.5 years). Eventually, changes in their symptoms motivated most participants to seek advice. Most participants did not think the initial lump would be cancer, nor was a lump of any particular concern until symptoms changed.Conclusion. Given the frequency with which lumps are the first symptom noticed, raising awareness among participants that lumps should trigger medical consultation could contribute significantly to more rapid medical advice-seeking among women in Ethiopia. Primary care sites should be trained and equipped to offer evaluation of lumps so that women can be referred appropriately for assessment if needed.

Funder

AstraZeneca

Publisher

Hindawi Limited

Subject

Cancer Research,Pharmacology (medical),Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3